%0 Journal Article
%A Olma, Manuel C
%A Steindorf-Sabath, Lena
%A Tütüncü, Serdar
%A Kunze, Claudia
%A Fiessler, Cornelia
%A Kirchhof, Paulus
%A Dietzel, Joanna
%A Schurig, Johannes
%A Oschmann, Patrick
%A Niehaus, Ludwig
%A Urbanek, Christian
%A Thomalla, Götz
%A Nabavi, Darius G
%A Röther, Joachim
%A Laufs, Ulrich
%A Veltkamp, Roland
%A Heuschmann, Peter U
%A Haeusler, Karl Georg
%A Endres, Matthias
%T The Role of Atrial Fibrillation and Oral Anticoagulation Status in Health-Related Quality of Life 12 Months After Ischemic Stroke or TIA.
%J Brain and behavior
%V 15
%N 1
%@ 2162-3279
%C Malden, Mass.
%I Wiley
%M DZNE-2025-00111
%P e70248
%D 2025
%X Atrial fibrillation (AF) accounts for about 20
%K Humans
%K Atrial Fibrillation: drug therapy
%K Atrial Fibrillation: physiopathology
%K Atrial Fibrillation: complications
%K Quality of Life
%K Female
%K Male
%K Anticoagulants: administration & dosage
%K Aged
%K Ischemic Stroke: physiopathology
%K Ischemic Attack, Transient: physiopathology
%K Middle Aged
%K Prospective Studies
%K Aged, 80 and over
%K Administration, Oral
%K Severity of Illness Index
%K atrial fibrillation (Other)
%K ischemic stroke (Other)
%K oral anticoagulation (Other)
%K quality of life (Other)
%K transient ischemic attack (Other)
%K Anticoagulants (NLM Chemicals)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:39779216
%2 pmc:PMC11710889
%R 10.1002/brb3.70248
%U https://pub.dzne.de/record/275876